These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 17714061)
1. Non-corticosteroid therapy for the long-term control of asthma. Kelly HW Expert Opin Pharmacother; 2007 Sep; 8(13):2077-87. PubMed ID: 17714061 [TBL] [Abstract][Full Text] [Related]
2. Second-line controller therapy for persistent asthma uncontrolled on inhaled corticosteroids: the step 3 dilemma. Lipworth BJ; Jackson CM Drugs; 2002; 62(16):2315-32. PubMed ID: 12396225 [TBL] [Abstract][Full Text] [Related]
3. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma. Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409 [TBL] [Abstract][Full Text] [Related]
4. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma. Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological management to reduce exacerbations in adults with asthma: a systematic review and meta-analysis. Sin DD; Man J; Sharpe H; Gan WQ; Man SF JAMA; 2004 Jul; 292(3):367-76. PubMed ID: 15265853 [TBL] [Abstract][Full Text] [Related]
6. Association of Inhaled Corticosteroids and Long-Acting β-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent Asthma: A Systematic Review and Meta-analysis. Sobieraj DM; Weeda ER; Nguyen E; Coleman CI; White CM; Lazarus SC; Blake KV; Lang JE; Baker WL JAMA; 2018 Apr; 319(14):1485-1496. PubMed ID: 29554195 [TBL] [Abstract][Full Text] [Related]
7. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults. Ni CM; Greenstone IR; Ducharme FM Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751 [TBL] [Abstract][Full Text] [Related]
8. Omalizumab: an update on efficacy and safety in moderate-to-severe allergic asthma. Chipps BE; Figliomeni M; Spector S Allergy Asthma Proc; 2012; 33(5):377-85. PubMed ID: 23026179 [TBL] [Abstract][Full Text] [Related]
9. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Humbert M; Beasley R; Ayres J; Slavin R; Hébert J; Bousquet J; Beeh KM; Ramos S; Canonica GW; Hedgecock S; Fox H; Blogg M; Surrey K Allergy; 2005 Mar; 60(3):309-16. PubMed ID: 15679715 [TBL] [Abstract][Full Text] [Related]
10. Benefit-risk assessment of long-acting beta2-agonists in asthma. Jackson CM; Lipworth B Drug Saf; 2004; 27(4):243-70. PubMed ID: 15003036 [TBL] [Abstract][Full Text] [Related]
11. Long-acting beta-agonist treatment in patients with persistent asthma already receiving inhaled corticosteroids. Hancox RJ; Taylor DR BioDrugs; 2001; 15(1):11-24. PubMed ID: 11437672 [TBL] [Abstract][Full Text] [Related]
12. Combination therapy of bronchial asthma. Nelson HS Allergy Asthma Proc; 2001; 22(4):217-20. PubMed ID: 11552671 [TBL] [Abstract][Full Text] [Related]
13. Association of Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists With Asthma Control in Patients With Uncontrolled, Persistent Asthma: A Systematic Review and Meta-analysis. Sobieraj DM; Baker WL; Nguyen E; Weeda ER; Coleman CI; White CM; Lazarus SC; Blake KV; Lang JE JAMA; 2018 Apr; 319(14):1473-1484. PubMed ID: 29554174 [TBL] [Abstract][Full Text] [Related]
15. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma. Ducharme FM; Lasserson TJ; Cates CJ Cochrane Database Syst Rev; 2006 Oct; (4):CD003137. PubMed ID: 17054161 [TBL] [Abstract][Full Text] [Related]
16. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma. Ram FS; Cates CJ; Ducharme FM Cochrane Database Syst Rev; 2005 Jan; (1):CD003137. PubMed ID: 15674901 [TBL] [Abstract][Full Text] [Related]
17. Considerations in the long-term management of asthma in ambulatory patients. Williams DM Am J Health Syst Pharm; 2006 May; 63(10 Suppl 3):S14-21. PubMed ID: 16679425 [TBL] [Abstract][Full Text] [Related]